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Executive summary 
Context: The Scottish Government recognises the importance of decision support to improve 
knowledge management in health and care settings as a strategic priority.  To this end, they funded 
the 2015 National Decision Support Roadmap. This laid out a plan for procuring and building a 
Decision Support Platform delivering a range of small-scale demonstrators (including several mobile 
platforms for specific user groups e.g. polypharmacy and diabetes), and building clinician and policy 
engagement for further funding.  
Aims: We were commissioned to undertake a formative evaluation of the National Decision Support 
Programme to help facilitate the effective roll-out of systems included in the Roadmap more widely.  
Methods: We collected qualitative data through a series of in-depth interviews and observations of 
workshops demonstrating technological systems. Participants included policy makers and clinical 
leads involved in the National Decision Support Programme. As the Programme was in the early 
stages of strategy development and system implementation at the time of data collection, we focused 
on exploring expectations and drivers of Cambio (a pilot platform) being tested in primary care. This 
system delivers an open standards based algorithm editor and engine which is linked with bespoke 
decision support applications delivered as web and mobile products and integrated into primary care 
electronic health record systems. The web and mobile solutions linked to the Cambio algorithms 
platform were developed by Scottish partners (Tactuum and University of West of Scotland). 
Employing a flexible methodological approach tailored to changing circumstances and need offered 
important opportunities for realising true impact through ongoing formative feedback to policymakers 
and active engagement of key clinical stakeholders. Our work was informed by sociotechnical 
principles and a health information infrastructure perspective. Qualitative data were coded with the 
help of NVivo software and analysed through a combination of inductive and deductive approaches.  
Findings: We collected data through 30 interviews and eight non-participant ethnographic 
observations of early stakeholder engagement workshops. We developed and applied a theoretically-
informed evaluation framework, which we refined throughout our analysis.  
Overall, we observed a strong sense of support from all stakeholders for Cambio as an exemplar of 
an open standards based, customisable decision support platform, and proposals to roll this model 
out across NHS Scotland. Strategic drivers included facilitating integration of care, preventative care, 
patient self-management, shared decision-making, patient engagement, and the availability of 
information. However, in order to achieve desired benefits, participants highlighted the need for strong 
national leadership, system usability (which was perceived to be negatively affected by alert fatigue 
and integration with existing systems), and ongoing monitoring of potential unintended consequences 
emerging from implementations (e.g. clinical workloads).  
Conclusions and implications: In order to address potential tensions between national leadership 
and local usability as well as unintended consequences, there is a need to have overall national 
ownership to support the implementation of the Roadmap, whilst the implementation of individual 
applications needs to be devolved. This could be achieved through allowing a degree of local 
customisation of systems and tailoring of alerts, ongoing system development with continuing 
VWDNHKROGHUHQJDJHPHQWLQFOXGLQJ³KDQGs-RQ´H[SHULHQFHIRUFOLQLFLDQVDlimited number of pilots that 
are carefully evaluated to mitigate emerging risks early, and development of a nuanced benefits 
realisation framework that combines smaller and locally relevant measures determined by 
implementing sites with national progress measures.   
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Introduction 
There is a national strategic drive towards participatory, personalised, predictive and preventive 
medicine.(1) Decision support systems (DSS) are key enablers in the delivery of such a vision. DSS 
are characterised as information systems that draw on an active knowledge base to support the 
decision making of its user.(2) They are used globally by health and social care professionals and 
now also by citizens who have an interest in tracking and quantifying their health and activities (e.g. 
in diaries, appointment reminders, wearables). 
Electronic health record (EHR) infrastructures and the drive to integrate additional data streams, 
ranging from administrative, social, genetic and patient-generated wearable data, harbour the 
potential for a major step-change across the Scottish health and care landscape. Yet, using 
appropriate data to improve health and care outcomes, is dependent on an evidence-based strategy 
and associated delivery framework for a Scotland-wide DSS. This is reflected in the development of 
the national Decision Support Roadmap for NHS Scotland to support the implementation of the 
decision support objectives within the national eHealth Strategy.(3) The Roadmap widens the scope 
of DSS from professionals (which was the focus of the previous eHealth Strategy) to citizens and 
shared decision-making. The development of a new National Digital Platform is an associated new 
development and is in the longer term likely to have an impact on DSS.(4)  
Clinical decision support (CDS) systems are a subset of DSS used by clinicians drawing on real-time 
patient-specific information to generate individualised advice. They can be independent (apps or 
websites), interfaced (e.g. to patient management systems or portals) or integrated (with EHRs). CDS 
systems produce alerts (such as warnings and reminders) tailored to the individual case at hand. 
Some platforms can be accessed by clinicians, patients/citizens/carers and third parties, which is 
particularly relevant for social care providers and can promote shared decision making with citizens.  
CDS to support prescribing is a key strategic priority area throughout much of the world including 
Scotland, since medication-related harm is associated with a substantial proportion of potentially 
avoidable morbidity and mortality.(5-7) Real-time support and electronic alerts/prompts have under 
VRPH FLUFXPVWDQFHV GHPRQVWUDWHG EHQHILW LQ LPSURYLQJ FOLQLFLDQV¶ SUHVFULELQJ EHKDYLRXU DQGRU
reducing error rates, but there remains an important risk that CDS implementation can introduce new 
areas of clinical risk and unexpected threats to patient safety. Koppel and colleagues, for example, 
reported how fragmented computerised provider order entry (CPOE) displays prevented a coherent 
YLHZ RI SDWLHQWV¶ PHGLFDWLRQ DQG KRZ VHSDUDWLRQ RI IXQFWLRQV FRQWULEXWHG WR GRXEOH GRVLQJ RI
medication.(8) Another study has highlighted how implementation generated errors associated with 
the process of entering and retrieving information, and with communication and coordination 
processes.(9) Similarly, we have found that many systems can produce clinically spurious alerts, 
which frustrate end-users and results in these commonly being over-ridden or ignored.(10) More 
recent work has highlighted the potentially serious treatment delays that can inadvertently be 
DVVRFLDWHGZLWKWKHLQWURGXFWLRQRIµKDUGVWRSV¶WRUHGXFHULVNRIVHULRXVSUHVFULELQJHUURUV(11,12) This 
illustrates a need for careful evaluation of the introduction of such technologies and their impact.(13)  
We here report on the development and application of an evaluation framework for the Scottish 
National Decision Support Programme. This work is designed to help inform the ongoing development 
of the Roadmap through identifying early drivers and implementation strategies, anticipated 
challenges, and potential ways to address these. In doing so, we hope that our work will help to ensure 
that DSS are implemented/used in a way that is person centred, safe, reliable and inclusive whilst at 
the same time supporting service re-design and innovation. 
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Analytical approach and conceptual framework 
The development of our evaluation framework was based on the sociotechnical approach.(14) This 
focuses on exploring both structural technological factors and associated social processes as well as 
the interrelationship between the two during implementation and optimisation (see Figure 1). The 
sociotechnical approach has been applied widely to understanding, for example, how technological 
change can result in changes to work practices of healthcare professionals, and vice versa, how users 
can shape technological designs. 
The majority of existing empirical work on the implementation/optimisation of information systems and 
associated care and business process transformation across sectors ± i.e. not only in health and 
social care ± strongly suggests that paying attention to sociotechnical factors is imperative to achieve 
improvements in processes and outcomes. These are not only dynamically linked, but also evolving 
over time. Key tenets here include: 
x Achieving joint optimisation of social, technical and organisational sub-systems. Inadequate 
attention to one or more of these components may jeopardise optimisation of the whole system 
(e.g. focusing solely on improving technological functions may sub-optimise the overall system 
performance as humans will no longer be satisfied with their tasks and lose motivation).  
x As the technological, social and organisational sub-systems are interdependent (Figure 1), 
changes in one sub-system are likely to affect the other. Careful attention therefore needs to 
be paid to adjust work and organisational processes if technological elements are changed.  
   
Insights obtained through the application of the sociotechnical framework are formative and 
summative in nature, informing ongoing implementation/optimisation activities (the formative 
component), and also giving an overall assessment of merit (the summative component).(15-17) 
Figure 1: Illustration of sociotechnical systems 
 
 
 
In addition to sociotechnical approaches, we also drew on the health information infrastructures (HII) 
perspective. This highlights how simple, stand-DORQH³GLVFUHWH´LQIRUPDWLRQWHFKQRORJ\,7V\VWHPV
EHFRPHNQLWWHGWRJHWKHULQWRLQFUHDVLQJO\FRPSOH[³V\VWHPVRIV\VWHPV´DSS needs to be seen 
Wider macro-
environment
Organisational 
context
Social/human 
factors
Technological 
factors
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as one part of this evolving health information infrastructure. HIIs emerge and evolve over extended 
periods of time. They are never finished. Major upgrades (for example through the acquisition of a 
³PHJD-softwaUH´SDFNDJHVDUHH[WUHPHO\H[SHQVLYHVORZDQGGLIILFXOWWRLPSOHPHQW*HQHULFRSWLRQV
available within the package have to be matched against the specific methods and procedures of 
particular settings and specialties. Benefits evolve only slowly as organisational stakeholders learn to 
exploit the new functionality. Eventually the package becomes taken for granted ± ³LQYLVLEOHH[FHSW
RQEUHDNGRZQ´± when organisation members feel they cannot do their work without it.(19) 
Aims and objectives 
The methods of this work have evolved significantly over the course of the project. When 
commissioned, our aims were to: 
1. 'HYHORSDQHYDOXDWLRQIUDPHZRUNWRHQDEOH6FRWODQG¶VKHDOWKDQGVRFLDOFDUHWRPHDVXUHDQG
optimise the impact of developments delivered through the national Decision Support 
Roadmap 
2. Refine this framework and apply it to selected settings (i.e. the Demonstrator Projects 
delivered through the Roadmap currently in progress)  
3. Inform the development of the national decision support infrastructure and its roll-out by 
providing formative and summative feedback to Scottish Government and NHS Scotland 
eHealth Leads 
To keep the project manageable and achieve immediate impact, we decided in collaboration with 
funders to apply the evaluation framework to the Cambio system in primary care rather than the full 
range of demonstrator projects included in the Roadmap. This focus would mean that the work could 
contribute to the business case for national roll-out and continuous evaluation of DSS in Scotland.  
Methods 
We originally proposed three complementary work packages (WPs, see Figure 2).  
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Figure 2: Illustration of the three originally proposed WPs 
 
A detailed outline of the original protocol in provided in Appendix 1.   
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After liaising with funders and scoping existing needs, the methods were revised to reflect a closer 
focus on the various stakeholder needs and the potential impact delivered through the Cambio 
decision support platform (Figure 3) in primary care. Cambio integrates with primary care systems to 
combine patient-specific information with existing guidelines. It issues alerts and provides applications 
including shared decision-making tools in the context of the individual patient record. These alerts 
and applications provide recommendations and options to guide clinical decisions and shared 
decisions in collaboration with patients. Applications are delivered as web solutions and downloadable 
mobile apps as well as embedding in the patient record. The open standards based approach adopted 
by Cambio means that it is vendor-neutral, so can provide a common decision support platform that 
integrates with multiple EHR systems. 
The implementation of decision support in live electronic health record systems is dependent on the 
approval of a national business case and on implementation of new and updated primary care 
systems through a major reprocurement process taking place at the same time as the DSS pilot. 
Therefore, while the mobile and web solutions were released as live products, embedding of DSS 
could at the time of the research only be observed in test environments. We therefore decided to 
focus on qualitative methods of enquiry, as concrete outcome measures would not be realised during 
our work. 
 
Figure 3: Illustration of the three revised WPs
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The 2015 DSS Roadmap was informed by a literature review of DSS in health and social care settings 
conducted by Scottish Government in 2014.(20) This clearly highlighted the significant potential of 
these systems. Since then there has been increasing policy interest the potential of DSS linked to 
artificial intelligence (AI) and machine learning (ML),(21,22) but these are new technologies and their 
impact and associated challenges are to date uncertain. Therefore, we began a systematic literature 
review to identify the existing evidence base surrounding the effectiveness of data-driven AI to support 
decision making in health and social care, which is still in progress (see Appendix 2 for protocol). 
Ethical approval 
We obtained Institutional Review Board (IRB) approval for interviews and observations from the 
Centre for Population Health Sciences at The University of Edinburgh. All places, names and 
organisations have been anonymised to ensure confidentiality. Individual participants provided written 
informed consent for participation.  
Design  
We conducted a formative qualitative longitudinal evaluation consisting of a combination of face-to-
face/telephone interviews and observations of workshops with representatives of 
different stakeholder groups including policy and strategy leads, system vendors and clinical opinion 
leaders (primarily general practitioners (GPs) and pharmacists). 
 
Sampling  
Sampling was facilitated by Scottish Government who helped to establish contacts with key 
stakeholder groups. We used purposeful sampling to select stakeholders that were involved in 
planning, comissioning, development, and early testing/use of Cambio and DSS more generally.(23) 
We attempted to ensure maximum variation in terms of background (clinical, managerial, strategic) 
and geographical location.  
 
To address the potential risks of bias caused by purposeful sampling facilitated through Scottish 
Government, we used a degree of respondent-driven sampling to promote a maximum variation 
sample.(24) 
  
Data collection  
We used semi-structured interviews as the main method of data collection. We also undertook non-
participant observation of workshops where Cambio with its linked web and mobile solutions was 
demonstrated to clinical leads to observe the dynamics of prospective user reactions in situ (see 
Appendix 3 for interview topic guides and observation recording sheet). Combining different methods 
enabled us to triangulate the data sources to validate emerging findings.(25) 
 
The interviews consisted of open-ended questions about the experiences of existing solutions and 
expected outputs of a Scotland wide system. The interview guides were tailored to the roles and 
organisations of individuals. Each interview took between 20 minutes to one hour. Interviews with 
policymakers explored strategic drivers for decision support systems and how these fit within the 
wider political and supplier landscape within NHS Scotland. Interviews with clinicians explored their 
attitude towards DSS, how it would impact their work and how it could be integrated with existing 
practices and designed most successfully.   
 
During workshops, the researcher (MC) recorded the layout of the room, the actors and their roles, 
how Cambio with its linked web and mobile solutions was perceived to be received, emerging attitudes 
DQGUHDFWLRQVDQGWKHUHVHDUFKHU¶VRZQLPSUHVVLRQVIHHOLQJVLQUHODWLRQto the observation. 
 
With written consent from participants, interview data were digitally audio-recorded and transcribed 
verbatim by a professional transcriber. The researchers (KC and MC) also recorded fieldnotes. 
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Data analysis  
Data were thematically analysed, initially within WPs in order to explore different viewpoints and 
triangulate data sources.  We drew on our previous work in this area as a deductive coding framework, 
where possible. In addition, we inductively identified emerging themes.(26) Themes were developed 
based on frequency of occurrence and salience amongst different stakeholder groups. Negative 
cases, i.e. those that did not fit within the narrative, were explored, keeping potential implications for 
the national DSS strategy and evaluation framework in consant focus. 
 
Findings across WPs were then compared in analysis meetings of the research team. This involved 
discussing commonalities and differences across data sources and participant groups, as well as 
exploring potential underlying explanations for differences and remaining tensions. Although we 
observed subtle differences across participant groups (which we explain in the Results section), our 
general findings were comparable, so consensus was achieved though aggregating findings at higher 
analytical levels. 
Development of evaluation framework 
The evaluation framework is shown in Table 1 (we also provide an extended version in Appendix 4). 
It was developed iteratively based on emerging findings and the existing literature. We updated our 
previous work exploring the implementation and adoption of health information systems records as a 
basis for developing the initial version of the evaluation framework.(27) In doing so, we identified 
technological, social/human, organisational and wider macro/environmental dimensions, which we 
integrated with more recent literature (Figure 1). Each of the overall headings in the evaluation 
framework includes a range of more detailed evaluation questions that we have iteratively built on 
during the conduct of this evaluation.  
However, it is important to note that these factors are both interrelated and context dependent (in line 
with our analytical framework), somewhat complicating the conclusions that can be drawn. Even if all 
factors are adequately attended to, this does not necessarily guarantee implementation success. 
Dimensions are also evolving over time, necessitating frequent updating of the framework. It is further 
important to note that, as the system was still being developed and was not ³live´at the time of data 
collection, stakeholders commented on their perceptions of the system based on workshop 
demonstrations rather than based on hands-on experience in real-world situations.
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Table 1: Evaluation framework for the National Decision Support Roadmap 
Technological 
factors 
Usability Performance Adaptability 
and flexibility 
Dependability Data 
availability, 
integrity and 
confidentiality 
Data accuracy Sustainability  
 What is the 
ease of use and 
learnability of 
the technology? 
Does the 
technology function 
as intended by 
developers? 
Can system 
design be 
changed to 
some extend to 
suit emerging 
needs? 
Is the system 
reliable and 
stable? 
Is data held 
within the 
system 
available, 
accessible and 
usable to those 
who need it? 
Is the data held in 
the system 
accurate? 
Is use of the 
technology 
sustainable? 
 
Social/human 
factors 
User 
satisfaction 
Complete/correct 
use 
Attitudes and 
expectations 
Engagement Experiences Workload/benefits Work processes User input in 
design 
 Are users 
satisfied with 
the technology? 
Are features and 
functionality 
implemented and 
used as intended? 
What benefits do 
users expect 
from using the 
technology and 
how can these 
be measured? 
Are users 
actively engaged 
in 
implementation, 
adoption, and 
optimisation? 
Have users got 
negative 
experience with 
previous 
technologies? 
Are the benefits and 
efforts relatively 
equal for all 
stakeholders? 
Does the system 
change 
relationships with 
patients, patterns 
of communication, 
and professional 
responsibilities 
(e.g. increase of 
administrative 
tasks)? 
Is there effective 
communication 
between 
designers, IT 
staff and end-
users as well as 
between 
management 
and end-users? 
Organisational 
context 
Leadership 
and 
management 
Communication  Timelines Vision Training and 
support 
Champions Resources Monitoring and 
optimisation 
 Are 
management 
structures to 
support the 
implementation 
adequate? 
Have aims, 
timelines and 
strategy been 
effectively 
communicated? 
Are 
implementation 
timelines 
adequate? 
What benefits do 
organisations 
expect from 
implementing the 
technology and 
how can these be 
measured? 
Is the training 
adequate and 
realistic? 
Are champions and 
boundary spanners 
effectively utilised? 
Is implementation 
adequately 
resourced? 
(includes 
technology, 
change 
management and 
maintenance) 
Is system 
performance and 
use monitored 
and optimised 
over time? 
    Is a coherent and 
realistic vision 
driving 
developments? 
   Are lessons 
learnt captured 
and incorporated 
in future efforts? 
Wider macro-
environment 
Media Professional 
groups  
Political 
context 
Economic 
considerations 
and incentives 
Legal and 
regulatory 
aspects 
Suppliers  Measuring 
impact  
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 How is the 
technology 
viewed by the 
media? 
How is the 
technology viewed 
by professional 
groups? 
What benefits do 
policymakers 
expect from the 
technology and 
how can these 
be measured? 
Are there clear 
incentives for 
organisations 
and users to 
implement? (e.g. 
improvements in 
quality of care) 
Have legal and 
regulatory 
frameworks 
been 
established? 
Is supplier 
management 
effectively 
organised? 
Are various 
stakeholders 
working together 
to define, validate, 
test and refine 
outcome 
measures and 
measurement 
strategies?  
 
   What is the 
national 
approach to 
achieving 
interoperability 
and does the 
system align 
with this? 
Is sufficient 
funding in place 
to support the 
initiative? 
  Are outcome 
measured 
important, 
clinically 
acceptable, 
transparent, 
feasible and 
usable? 
 
   Is there a 
coherent vision, 
consistent 
approach and a 
clear direction of 
travel allowing a 
degree of local 
input? 
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Results 
We conducted 30 one-to-one interviews and observed eight workshops between 10th of May 2018 
and 30th of October 2018. Participants interviewed are summarised in Table 2.  
Table 2: High-level interview participants  
Participant number 
 
Gender Background 
1 Male Primary care 
2 Female Social care 
3 Male Patient 
4 Male Performance and delivery 
5 Female Prescribing 
6 Male Public health 
7 Female Planning and quality 
8 Male Doctor 
9 Male Developer 
10 Female Social services 
11 Female Public health 
12 Female Nursing 
13 Male Doctor 
14 Male Doctor 
15 Male Consultant 
16 Male GP 
17 Female Pharmacist 
18 Male GP 
19 Female Pharmacist 
20 Male GP 
21 Male GP 
22 Male Pharmacist 
23 Male GP 
24 Female Pharmacist 
25 Male GP 
26 Male GP 
27 Female GP 
28 Male GP 
29 Female GP 
30 Male Pharmacist 
 
The following paragraphs will summarise our emerging findings. We have identified four key themes 
which we explore in detail with illustrative quotes: 
x Widespread recognition of the potential value of DSS 
x Leadership and strategy to implement DSS nationally 
x The important role of usability and interoperability 
x Potential of unintended consequences emerging from implementations 
Widespread recognition of the potential value of DSS 
All interviewees and workshop attendees agreed that, in line with existing empirical evidence, the 
strategic decision to implement DSS in NHS Scotland was the right way forward. 
³:LWKJRRGVXSSRUWLYHGHFLVLRQ-making, people have a better chance of getting the right care 
at the right time in the right place. Not the wrong care too late at excessive cost, with disabling 
FRQVHTXHQFHV´ Participant 1, Male, Policy 
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Participants expected DSS to have a positive impact on safety, quality and efficiency. Areas and 
potential outcomes mentioned most frequently are summarised in Table 3.  
Table 3: Expected areas of impact and potential outcomes of DSS 
Expected area of DSS impact Potential outcomes 
Integration of care through securely shared digital 
information across primary, secondary and social care 
settings 
Reduced duplicate data entry 
Patient satisfaction/feedback (by not being asked the 
same questions in a variety of settings, especially 
those with multiple chronic conditions) 
Frequency of medication reviews at care transitions 
Medicines reconciliation between care settings 
Reduction in delayed discharge 
Improved data availability 
Adherence to guidelines  Reducing inappropriate variation of clinical practice  
Improved adoption of current evidence in clinical 
practice 
Patient self-management Adherence to treatment regimen 
Patient access to digital records and illness/ wellness 
information 
Reduced travel for patients 
Reduced visits to primary care 
Improved patient quality of life 
Improved patient autonomy/confidence in managing 
chronic conditions 
Patient engagement and shared decision-making by 
supporting clinicians to explain choices of treatment 
and reasons for prescriptions 
Patient access to digital records, consultation 
information, and digital information tailored to them 
Patient and carer involvement in determining their own 
needs and outcomes 
Supported self-management for patients 
Improved patient confidence in discussing their care 
needs with clinicians and in making treatment choices 
Increased involvement of social care 
Improved attitude amongst and training for clinicians 
towards shared decision-making 
Patient satisfaction 
Availability of appropriate information tailored to the 
needs of patients and clinicians 
 
Facilitating access to relevant information when it is 
needed 
Facilitating access to up-to-date evidence 
Time savings for clinicians Less time spent manually searching through 
guidelines 
Shorter length of appointments 
Increased patient contact 
Shorter appointments  
Supporting changing roles within the multi-disciplinary 
healthcare team e.g. facilitated delegation of patients 
with less complex needs to other practice staff (e.g. 
pharmacists, nurse practitioners) 
 
The expected areas of impact frequently aligned with important policy drivers around guideline 
implementation and Realistic Medicine.(28) For example, stakeholders talked of giving patients more 
power to decide on their own treatment.  A typical response was: 
³«the drive with the polypharmacy guideline and realistic medicine [will] help doctors to have 
DEHWWHUXQGHUVWDQGLQJRIWKHULVNVDQGEHQHILWVRIWUHDWPHQWVWKDWWKH\¶UHRIIHULQJWRWU\DQG
help patients have and then, as a knock-on effect, patients have a better understanding of 
risks and benefits of a treatment that is being considered..´ Participant 22, Male, Tayside 
Pharmacist 
However, the definition of outcome measures was perceived to be difficult and the long time to realise 
potential benefits was highlighted. Participants also acknowledged that outcomes would be 
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dependent on the DSS application in question, and some interviewees were not entirely clear which 
functionality was included in the Roadmap. 
³, FRPH DFURVV GHFLVLRQ VXSSRUW LQ YDULRXV GLIIHUHQW JXLVHV 2U IRU ZKDW , ZRXOG FRQVLGHU
GHFLVLRQVXSSRUW´ Participant 13, Male, Clinical Lead 
Despite the overall positive attitudes amongst participants, we also observed concerns that 
expectations may not necessarily match system functionality. For example, many clinicians discussed 
a more general problem of information overload and the difficulty of navigating different sources of 
information. One GP stated that she often had open 10 tabs on her computer at a time, whilst another 
mentioned going in and out of different systems, and several stated carrying folders of paper-based 
records. Participants therefore highlighted evaluation of benefits as a priority area. 
Leadership and strategy to implement DSS nationally 
Whilst no participant expressed a negative opinion on the concept of DSS, early and ongoing 
engagement with clinicians and other healthcare staff was viewed as crucial during system 
development and implementation. At one workshop, a male GP emphasised that his comments 
should not be seen as negative but ³LQWKHVSLUWRILPSURYLQJWKHV\VWHP´. Typical comments in relation 
Cambio were:  
³6RWKHLUIRUZDUGWUDYHOVHHPVWREHLQWKHULJKWGLUHFWLRQSURYLGLQJWKDW«WKHILQDOSURGXFWZLOO
ZRUNDV LW¶VVXSSRVHG WRZRUN«ZH¶YHJRW10 minutes. That has a big impact on your time 
whereDVLI\RX¶YHJRWVRPHWKLQJSRSSLQJXSWKDWFDQGRWKHVHWKLQJVWKHQLWVKRXOGZRUNIDU
PRUHHIILFLHQWO\´ Participant 20, Female, GP, Tayside  
Ongoing stakeholder engagement was also stated to be necessary to raise the profile of the Roadmap 
amongst the wider healthcare workforce. 
³7KHDFWXDOZRUNVKRS«ZDVDJRRGVWHSLQWKHULJKWGLUHFWLRQEXW,WKLQNIRUSHRSOHZKRDUHQ¶W
aware of these things, not just GPs but pharmacists, nursing and other kind of clinicians, I 
think a wee bit of work needs to be done to raise its profile. I really enjoyed looking at the 
VFUHHQVDQGVDZJUHDWSRWHQWLDO´  Participant 27, Female, GP, Glasgow  
We also observed a tension between a perceived lack of strong national level leadership (which was 
considered to be needed for the successful implementation of the strategy) and staff changes within 
the eHealth Directorate at Scottish Government. Several interviewees stated that these changes 
caused challenges surrounding strategic priorities and direction of travel. 
³«P\SUHIHUHQFHLV«ZHKDYHDVHQVHRIZKHUHZH¶UHJRLQJWRSULRULWLVHWKHLQLWLDOLQYHVWPHQW
and that that is all coordinated from the one position, rather than from a variety of different 
SLHFHPHDOSRFNHWVDQG IXQGHG«LWQHHGV WKHFHQWUDO FRRUGLQDWLQJ IXQFWLRQ´ Participant 13, 
Male, Clinical Lead 
Whilst calling for central leadership and direction, participants also acknowledged that a variety of 
different projects had to be managed under a portfolio-based approach. Here, there appeared to be 
a tension between the perceived need to have a firm direction of travel beyond Cambio 
implementation and the multitude of ongoing DSS initiatives across settings (including primary, 
secondary and social care). Whilst leadership was seen to be required to ensure alignment of 
initiatives and avoid silos, there was also a perceived need to recognise that strategy was sufficiently 
agile to cope with changing demands and stakeholder experiences. 
³,WKLQN>&DPELR@LVRQHRIWKHSRWHQWLDOZD\V«WKHIDFWWKDWWKHUH¶VDQXPEHURIpilots which have 
been started to test and to see what learning we can take from that, to me feels that the right 
DSSURDFK%XW LWPLJKWQRWEH WKHRQO\DSSURDFK«ZHKDYH WRPDNHVXUH WKDWZH ORRNVOLJKWO\
EH\RQGWKDWWRVD\RND\DQGWKLVLVZKDWZH¶YHJRt, this is the tools that we have in the here and 
16 
 
WKHQRZ%XWZHNQRZWKDWWKHZRUOGLVFKDQJLQJ«DVWHFKQRORJ\¶VFRQFHUQHGLW¶VFKDQJLQJUHDOO\
UHDOO\TXLFNO\6RZHQHHGWREHSUHSDULQJRXUVHOYHVIRUWKDWQH[WOHDSDVZHOO´ Participant 12, 
Female, Policy 
System usability and interoperability 
The Digital Health and Care Strategy provides a mandate for integration of digital health systems in 
Scotland and Cambio (which adheres to OpenEHR and Fast Healthcare Interoperability Resources 
(FHIR) open standards) fits in well with this.(21) However, it did at the time of our work not integrate 
with EMIS and Vision, primary care systems procured centrally in Scotland. Participants expressed 
hope that this integration would be possible in the future. In the interim, developers had created 
temporary interfaces.  
 
³, WKLQN LWZLOOKDYHWR>LQWHJUDWH@EXWKRZZHJHW WR WKDWSRLQW ,
PQRWVXUH 6RZHGRKDYHD
contractual requirement for [developer] to deliver, and interact with our clinical decision support 
V\VWHPV6RDQ\VXSSOLHUZRXOGQRWLRQDOO\DWOHDVWKDYHWREHDEOHWRGRWKDW´ Participant 14, 
Male, Clinical Lead 
³:KDWZHGRQRZLVZHDUHXVLQJDGHPRQVWUDWRUHQYLURQPHQWZLWKWKHORRNDQGIHHOH[DFWO\OLNH
it will look in reality, but for the real integration we will most likely use a third-party developer in 
WKHILUVWSKDVH´ Participant 9, Male, Developer 
System integration was also perceived to be crucial from a usability viewpoint and clinical interviewees 
expressed strong concerns that Cambio may not effectively integrate with other primary and 
secondary care systems (as well as their existing inbuilt CDS). This lack of integration, it was feared, 
may lead to slowing down of existing systems and parallel data entry (leading to duplication and data 
inconsistency).  
³:H IHHO OLNHZH¶YHJRW ORWV RI V\VWHPV WKDWZRUN VHSDUDWHO\1RZ WKH\GRQ¶W WDON WRHDFK
other...so you end up having to put data into more than one system«so if they could talk to 
HDFKRWKHUDELWEHWWHU,WKLQNWKDWZRXOGKHOS´Participant 25, Male, Consultant, Tayside 
Another perceived factor potentially affecting end-user usability was perceived to be the degree of 
local customisation needed to tailor the number of pop-ups to local needs and avoid alert fatigue. 
Clinicians also mentioned that they were already presented with pop-ups in their own GP systems 
and that alerts from various sources needed to be aligned and thresholds for alerting set carefully in 
close consultation with them to ensure usability.  
³Pop-ups come up IURPDOO GLIIHUHQW SODFHV VR WKHUH¶V WKHQRWHV WKDW SUDFWLFHVSXW RQ WKH
systems to try and remind you to do something«\RX¶UHSRWHQWLDOO\JRLQJWRWKURZDQRWKHUVHW
of pop-ups in there to have youUFOLQLFDOGHFLVLRQVXSSRUW«´ Participant 21, Male, GP, Glasgow 
Potential of unintended consequences emerging from implementations 
As clinicians had only seen pilot versions of the software in test environments and some had previous 
negative experiences of using new digital systems, there were uncertainties around the use of Cambio 
in real-life settings. For example, clinicians mentioned the risk of duplication of work and increased 
workloads despite their desire for more time with patients. 
³« to introduce that amount of potentially new information into a consXOWDWLRQWKDW¶VYHU\
YHU\WLJKWWLPHZLVHLVDOZD\VJRLQJWREHDFKDOOHQJH´Participant 21, Male, GP, Glasgow 
It was also viewed as important avoid over-reliance and to ensure that the system did not attempt to 
replace the expertise of clinicians.  
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³,W¶VXVHIXOWRVHHDPRXQWRILQIRUPDWLRQDYDLODEOH, but it could lead you down the wrong 
pathway and be in charge rather than the doctor. They [GPs] have the background 
knowledge of the patient and want to use their expertise.´ Glasgow Workshop, Table 
Feedback 
Several stakeholders in the workshops and in interviews also highlighted some potential tensions 
between decisions of clinicians and patients, with GPs generally being more risk averse than patients. 
Some therefore argued that DSS should be patient-informed and not patient-led, with the ultimate 
decision of treatment being in the hands of the clinician.  
³3DWLHQWVWDNHPRUHULVNVWKDQGRFWRUVEXWWKHFOLQLFLDQLVUHVSRQVLEOHIRUWKHPLWVKRXOGEH
patient-informed but not patient-leG´  Participant 20, Male, GP, Tayside 
Another concern expressed at workshops and in interviews was that, for clinicians, the Realistic 
Medicine policy may be in direct contrast to other policy drivers such as efficiency and patient 
outcomes. GPs described scenarios where patients might choose minimal intervention and therefore 
have a worse outcome.  
³<RX¶UH WU\LQJ WR UHGXFHYDULDELOLW\ IRUGUXJVHWc. but this can go against Realistic Medicine 
where you are giving personal choice. How can success be measured?´ Glasgow Workshop 
Table Feedback 
Discussion 
Summary of key findings 
Overall, we observed a strong sense of support from all stakeholders for the Cambio platform model 
and capabilities as well as associated plans to roll it out across NHS Scotland. Its development and 
implementation is well-aligned with existing strategic priorities and has traction with national clinical 
leads.  
As this was a first-of-type and as Cambio, at the time of our evaluation, only existed in pilot settings, 
there were also some tensions.  
Key observations in our work included:  
x Leadership: There was a perceived tension between strong national level leadership (which 
was perceived to be needed for the successful implementation of the strategy) and the 
ongoing changes at Scottish Government and staff changes within the eHealth Directorate.  
x Strategy: Participants highlighted that the perceived need to have a firm direction of travel 
beyond Cambio implementation may be at odds with the multitude of ongoing DSS initiatives 
across settings and including a multitude of different systems in various settings (e.g. Hospital 
Electronic Prescribing and Medicines Administration (HEPMA) in some hospitals, patient-
facing apps). 
x Benefits realisation: Policymakers highlighted the need for the Roadmap to align to existing 
national strategic priorities surrounding value and efficiency. Whilst clinical leads did not 
discount the importance of these, they did highlight emerging local priorities as being an 
important driver of adoption behaviour.  
x Usability and interoperability: Clinicians highlighted that degree of end-user usability of 
Cambio is dependent on: 1) the level of interoperability with primary and secondary care 
systems and, 2) the degree of local customisation to tailor the number of pop-ups to local 
needs and avoid alert-fatigue.  
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x Unintended consequences: Although clinicians stated that Cambio had the potential to save 
time allowing them to focus on more complicated patients, there were some concerns around 
duplication of work and increased workloads. 
Strengths and limitations 
This evaluation offered important opportunities for realising true impact through ongoing formative 
feedback to policymakers. In doing so, our written progress reports have informed a business case 
submitted to Scottish Government in October 2018 for further funding of the Cambio platform beyond 
pilot sites. Our methods also allowed to adjust flexibly to changing policy landscapes and emerging 
priorities and contributed to building clinical- and policy-level engagement.  
The formative real-time nature of this work has, however also posed some challenges for all involved. 
Changes in policy priorities and emerging findings necessitated flexible changes to our initially 
planned methodology over the course of our work in order to ensure that it remained relevant. For 
example, although we had initially planned to work with settings that had implemented systems as 
part of the Roadmap, only some functionality existed at the time we began our work.  
Moreover, our funders also acted as gatekeepers to participants and workshops. The sample may 
therefore not be representative of wider stakeholder groups surrounding the DSS landscape. As a 
result, our findings are likely to provide an incomplete picture of reality and should be interpreted with 
caution, despite (or precisely because of) fulfilling their purpose of delivering political impact.  
It is further important to recognise that this work presents only a snapshot of an early evaluation of 
the beginnings of a national programme. This calls for more in-depth and longitudinal work to assess 
ongoing developments over time.(29) For example, it was in some instances not clear to us if clinicians 
and policy makers really understood the implications of using Cambio iQ WKH ³UHDO ZRUOG´ DV WKH
workshop demonstrations were based on an idealised scenario. Real challenges may only come out 
when the system is used in practice.  
Integration of findings with the current literature 
Emerging issues in this work reflect tensions present in many large scale digital change initiatives in 
healthcare settings. Whilst the rationale for change and the value proposition of DSS was clear to all 
participants in this work, the leadership and governance model going forward was an important 
concern. One common theme was the agreement that there needed to be a mixture between ³bottom-
up´ and ³top-down´ approaches to implementation, ensuring a degree of central leadership and 
direction whilst also allowing for local input in decision making.(30) This balance is crucial, as many 
H[LVWLQJ ³IDLOHG´ FKDQJH LQLWLDWLYHV such as the National Programme for Information Technology 
(NPfIT) have illustrated that QDWLRQDO ³WRS-GRZQ´ approaches alone are insufficient to realise the 
anticipated benefits. In thH13I,7³WRS-GRZQ´VWUDWHJLHV were superseded by locally driven strategies 
and ultimately changed to a more ³middle-out´ model, where national strategic direction aligned more 
closely with local strategy.(31)  
Both clinical and policy stakeholders in our sample had a strong desire for systems to save time and 
improve safety, quality and efficiency of care. Time savings, however, stand in stark contrast to the 
often long and painful implementation experiences in healthcare settings where benefits of digital 
systems can take a long time to materialise, and where benefits are often not visible to those who 
take the additional burden associated with their implementation.(32,33) This long pathway to benefits 
is partly due to social dimensions surrounding the technology, including for example adverse impacts 
on work practices and increased workloads, the potential introduction of new errors, adverse impacts 
on time spent with patients, and unrealistic stakeholder attitudes/expectations.(34-36)  
Whilst most participants were optimistic in relation to potential benefits of Cambio, there were also 
some key concerns. These related mainly to the would-be adopters interacting with technologies, and 
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specifically usability and integration with existing workflows. Issues with system usability adversely 
affecting adoption patterns feature consistently in the empirical literature. In particular, the issue of 
alert fatigue in CDS and information overload amongst clinicians remains an unresolved area 
internationally.(37,38) There is a degree of trade-off between the number of alerts and the attention 
of clinicians, which has led some to advocate the use of a limited user-determined number of carefully 
designed pop-ups.(39)  
An increasing number of interfaces can adversely impact system performance and usability. They 
can also lead to the introduction of new errors.(40,41) We have shown this in the context of hospital 
electronic prescribing systems, where we observed that integration and interfacing problems in some 
cases inhibited effective information transfer, leading to duplicate data entry and adverse effects on 
the availability of information.(40,41)  
Policy recommendations and implications for practice 
Recognising the early stages of this evaluation, our work has some preliminary implications for policy 
to ensure long-term sustainable delivery of the Roadmap. Most importantly, sufficient time and 
resources need to be made available to implement Cambio and manage its optimisation over time. 
This will need to include plans for knowledge management with iterative stages involved in monitoring 
systems over time.(17)  
There is a need to have overall national ownership to support the implementation of the Roadmap 
within the eHealth Directorate potentially supported by NHS National Services Scotland as the 
delivery partner, whilst the implementation of individual applications needs to be devolved. This work 
also needs to be closely aligned with the development of the National Digital Platform as part of the 
wider HII and the wider Scottish Digital Health and Care Strategy to facilitate alignment with national 
strategic priorities.(4,18,19) Should this work not be supported going forward, there is a danger that 
stakeholders will be disillusioned and this may contribute to negative narratives surrounding national 
digital health initiatives in NHS Scotland.  
As technology landscapes and needs are constantly changing, future iterations of the Roadmap have 
to be sufficiently agile. Revisiting the original document at pre-defined time points informed by ongoing 
evaluation and stakeholder engagement is likely to facilitate these developments. This should also be 
accompanied by ongoing communications about the current strategy and associated timescales, 
VWDNHKROGHUHQJDJHPHQWRSSRUWXQLWLHVDQG UHVXOWLQJDFWLRQV DVZHOO DV ³KDQGV-RQ´H[SHULHQFHRI
system use.  
 
In order to promote usability, there is a need to negotiate seamless integration with existing primary 
care systems, as temporary interfaces can adversely impact on user experiences. The negotiation 
with primary care system suppliers and promoting seamless integration through effective user 
interfaces is therefore key going forward. At the time of writing, Cambio does not integrate with the 
three re-procured GP systems that have now been confirmed for use in primary care from 2020 
onwards, but agreement with suppliers to implement this integration has been reached.  
 
There are further a number of potential ways to tackle tensions between local and national dynamics. 
We recommend the following:  
x Developing a strategy allowing for a degree of local customisation of systems and managed 
tailoring of alerts. The devolving of responsibility to local level needs to be tempered by the 
legal requirement to comply with the Medical Device Regulations for DSS that are classified 
as medical devices. 
x Ongoing system development and optimisation with continuing stakeholder engagement 
LQFOXGLQJ³KDQGV-RQ´H[SHULHQFHIRUFOLQLFLDQV 
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x Local organisations need to recognise the value of systems ± a limited number of pilots that 
are carefully evaluated will help to engage other organisations yet to implement and will help 
to identify and mitigate emerging risks early. 
x There is a need to develop a nuanced benefits realisation framework that combines smaller 
and locally relevant measures determined by implementing sites with national progress 
measures. 
Promoting informal knowledge flows to create a national digital learning economy surrounding 
Cambio will be an important accelerator of learning going forward. This may consist of for instance 
creating national risk registers or sharing of implementation and optimisation experiences through 
formal and informal channels. 
 
As this evaluation has focused on the very early stages of piloting, our findings are preliminary. We 
strongly recommend ongoing formative evaluation of DSS implementation through longitudinal work 
to ensure effective alignment with wider strategy, and continuous stakeholder engagement. This work 
needs to include a designated strand exploring evolving policy and supplier landscapes and market 
management. Our evaluation framework developed as part of this work, is designed to guide 
implementers and evaluators through this journey (see Appendix).  
Conclusions 
We have laid the early foundations for a formative longitudinal evaluation of the DSS Roadmap in 
Scotland. Our work has helped to promote early engagement of key stakeholders and also informed 
policy planning by identifying key clinical and political drivers of systems implementation, and 
challenges that are likely to warrant negotiation going forward. These include achieving a balance 
between national targets and local incentives, system usability, and benefits realisation. Careful 
ongoing formative evaluation guided by the developed evaluation framework developed as part of this 
work will help systems to realise their maximum potential whilst minimising disruption to existing 
services. 
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Appendix 1 ± Original study protocol 
WP1: Creation of an evaluation framework for decision support solutions in Scotland 
This WP will be concerned with developing an initial evaluation framework that will then be applied 
and refined in the subsequent WPs. WP1 will consist of two components: 
x WP1a - Exploring the relevant academic and grey literature and undertaking interviews with 
key topic experts: This will involve a review of the existing literature to scope existing national 
and international DSS developments, outcome measures, and evaluation frameworks. It will 
build on previous systematic reviews we have been involved in on EHRs, CPOE, DSS, 
telehealth, and consumer informatics tools.(1) Approximately five targeted qualitative 
interviews with key international experts will complement this. We have previously used this 
approach and found it to be very helpful in adding depth of insight.(2) We will begin by 
consulting individuals who we already have established relationships with and who are 
international leaders in the field of DSS and wearables (Prof Robert Greenes from Arizona 
State University and Prof Karandeep Singh from the University of Michigan).(3) We will draw 
on the DSS knowledge management lifecycle as an initial structure for the first iteration of the 
evaluation framework.  
x WP1b - Assessing to what extend the developed framework is applicable to Scotland and 
exploring existing barriers/facilitators to its application: In order to refine the framework 
developed in WP1a and explore potential barriers to and facilitators for its application, we will 
conduct approximately 10-15 interviews with selected representatives of different stakeholder 
groups including health and social care providers from Demonstrator Projects of the Roadmap, 
policymakers, system vendors (including app developers, TrakCare, Cambio Healthcare 
Systems), and healthcare managers. Participants will be snowball sampled in collaboration 
with the funders, through our extensive existing networks, the Scottish Government and 
Healthcare Improvement Scotland. We will attempt to ensure maximum variation in terms of 
background (clinical, managerial, strategic) and geographical location. Discussions will be 
structured around the evaluation framework components identified in WP1a including 
evaluation methodology, definitions of success, quantitative indicators and risk management. 
They will be digitally recorded and transcribed verbatim for analysis. The number of interviews 
will be determined through the principle of thematic saturation, that is we will stop collecting 
new data when no significantly new themes emerge in the concurrent analysis. Thematic 
analysis will lead to the creation of a refined evaluation framework.  
Deliverables 
x Completion of a draft evaluation framework for DSS in Scotland (there may be more than one 
suitable framework version tailored to different health and social care settings)  
x Completion of alignment of the framework with the higher-level evaluation of the Primary Care 
Strategy 
WP2: Application and piloting of the framework 
The prototype framework developed in WP1 will then be refined throughout WP2 through identifying 
barriers and potential strategies to overcome these to maximise successful routine application. We 
will initially pilot and refine quantitative indicators for impact assessments on dummy datasets, in order 
to minimise disruption to NHS services and explore potentially adverse consequences early. We have 
access to asthma related data using the Optimum Patient Care Research Database (OPCRD) free of 
charge. This has data on six million patients and is available in the University safe haven following 
development of an Anonymised Data Ethics & Protocol Transparency Committee (ADEPT) protocol.   
Design: We will then explore how applicable and useful the framework is by testing it in four early 
adopter projects that have developments planned or underway as part of Phase 2 of the Roadmap 
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(i.e. DSS functionality delivered through EMIS-PCS, mobile apps, rule-based platforms, web page 
access linked to TrakCare). These settings will be conceptualised as case studies and purposefully 
sampled according to type outlined in the Roadmap (increased shared decision-making, self-
management and enablement, personalised care provided closer to home, focus on quality and 
reducing unwarranted variation).(4) 
Sampling: Within each case, we will use purposive sampling to identify a diverse range of 
stakeholders including users of the technology (health and care staff, patients, citizens), implementers 
(managers), and system vendors (those providing individual systems, hardware, as well as 
infrastructures, including app developers, TrakCare, Cambio Healthcare Systems, EMIS Health).   
Data collection: Data collection at each site is anticipated to consist of semi-structured in-depth one-
to-one or (if necessary due to distance or more convenient for interviewees) telephone interviews 
(approximately six per case study site) to capture perspectives on different components of the 
evaluation framework. We have considerable experience with conducting such case studies.(28,29) 
Interviews will be conducted with topic guides exploring views on usability, integration, expected and 
experienced benefits, early experiences, lessons learnt, safety threats, and perceived 
barriers/facilitators. They will, with permission, be recorded and transcribed verbatim together with 
accompanying field notes. 
Data generation will end when saturation has been reached and no new relevant data are being 
collected. The above described numbers of interviews are based on our previous experience and 
should therefore be seen as indicative; they will be adjusted as necessary. 
Analysis: Qualitative data collection and analysis will be iterative, allowing emerging themes to be 
explored further and disconfirming evidence to be sought. Thematic analysis will allow us to access 
a diverse range of settings/uses, interviewees/perspectives, technologies and contexts. Detailed 
within case analysis will be followed by analysis across cases to identify over-arching themes, 
similarities and differences between cases, and implications for revising the evaluation framework. 
Our findings will feed into Phase 3 of the Roadmap (i.e. the national roll-out of the decision support 
infrastructure). 
Deliverables 
x Production of quantitative indicators for the framework 
x Completion of framework application to selected settings and report on impact of the decision 
support developments delivered through the Decision Support Roadmap 
x Production of version two of the framework based on this 
WP3: Facilitating continuous evaluation and quality improvement of decision support 
solutions and their implementation 
This WP will explore the potential applicability of the framework beyond case study settings and inform 
its roll-out nationally (Phase 3 of the Roadmap).  
Design: We will conduct a multi-disciplinary round-table discussion in focus group format with a 
designated facilitator to explore different perspectives and dynamics. We have significant experience 
with this format.(5-7) 
Participants: Participants will be purposefully sampled for maximum variation to consist of a diverse 
range of stakeholders including Scottish policymakers, representatives from industry, patients/citizens 
and carers, and health and care staff from case study sites identified in WP2. We anticipate up to 15 
participants to join, from a range of geographical locations. 
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Data collection: The preliminary evaluation framework will provide structure to the discussion, 
focusing on placing it within the wider socio-political context and on identifying mechanisms for 
continuous refinement structures (including services and resourcing required to support evaluation, 
governance structures and processes, how to address barriers and facilitators, and potential future 
developments e.g. wearables). The group discussion will be audio-recorded and transcribed. In 
addition, we will take field notes relating to perceived dynamics and interactions between participants. 
Data analysis: Transcribed data will be integrated (triangulated) with findings from WPs 1 and 2. This 
will involve combining findings, identifying common themes, and consolidating these in the refined 
evaluation framework and implementation roadmap; as well as examining areas of convergence and 
divergence. It will also involve integrating findings with the theoretical frameworks outlined above. 
Results will be fed back to and discussed with Scottish Government and NHS Scotland leads in 
eHealth. 
Deliverables 
x Production of the third iteration of the framework  
x Release recommendations on the service model for application of the evaluation framework 
to continuously monitor and maximise impact of decision support 
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Appendix 2 ± Investigating the use of data-driven artificial intelligence 
in health and social care decision support systems: a systematic 
review protocol 
Background 
x Increasing focus on health information technology (HIT) to improve quality, safety and 
efficiency of care 
x Decision support systems (DSS) have been shown to impact on improving practitioner 
performance 
x Significant potential of DSS linked to artificial intelligence (AI) and machine learning (ML) in 
this respect but these are new technologies and their impact and associated challenges are 
to date uncertain  
Definitions 
x AI can be defined as a technology or system that can emulate human performance typically 
by learning, coming to conclusions, appearing to understand complex content, engaging in 
natural dialogues with people, enhancing human cognitive performance or replacing people 
on the execution of non-routine tasks 
x AI technologies can be divided into two broad categories: 
o Data-driven AI: typically these technologies are driven by analysis of patterns and 
PRGHOVHPHUJLQJIURPYHU\ODUJHGDWDVHWVµ%LJ'DWD¶ 
o Knowledge-driven AI: takes the form of expert systems ± software that is programmed 
to provide advice. These technologies are driven by logical reasoning through an 
existing knowledge base ± often from research or guidance where data has already 
been synthesised and analysed. 
x In reality there is some overlap between the two types of technologies, as the existing research 
knowledge base can feed into ML technologies, and algorithms derived from other types of AI 
can feed into expert systems. 
Overall aim 
The overall aim of this work is to identify the existing evidence base surrounding the effectiveness of 
data-driven AI to support decision making.  
Research questions 
x What types of data-driven AI are used to support decision-making in health and social care 
settings? 
x What is the evidence surrounding effectiveness of AI to support decision-making in improving 
the quality, safety and efficiency of care? 
P (population) Health and social care users (patients and citizens), healthcare 
professionals 
I (intervention) 
 
 
AI used to support decision making 
C (comparator(s)) Non-AI based approaches 
O (outcomes) Practitioner performance 
Patient outcomes 
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METHODS AND ANALYSIS 
Design 
We will undertake a systematic review of published empirical research. 
 
Eligibility criteria 
We will include studies in health and social care settings published in English that focus on: 
x ML, natural-language processing (NLP) and deep learning  
x the use of systems for clinical, managerial and self-management decision-making 
 
The following study designs will be potentially eligible for inclusion: 
¾ Randomised controlled trials (RCTs)  
 
Studies will be excluded if they: 
¾ Fall outside our scope of interest, for example if they:  
o Evaluate technology that is not commonly associated with technologies that are driven 
by analysis of patterns and models emerging from very large datasets  
o Focus on the implementation of HIT in developing countries due to different contextual 
circumstances 
o Include settings that are outside health and social care 
 
Outcome measures 
¾ Primary outcomes 
o Impact on practitioner performance 
o Impact on patient outcomes  
¾ Secondary outcomes 
o Methods used 
o Intervention/technology 
 
Search methods 
We will search the published empirical literature from 2013 until 2018 for work investigating AI to 
support decision making. We will search the following major biomedical databases: MEDLINE and 
EMBASE.  
 
We will also search the following specialist databases and conference repositories, as much work in 
this area in not published in biomedical sources: IEEE Xplore, Annual Conference on Neural 
Information Processing Systems (NIPS), International Conference on Machine Learning (ICML), 
International Conference on Artificial Intelligence and Statistics (AISTATS) 
 
Specific search strategies will be employed for each database. 
 
Search terms 
We will divide search terms into three groups: 
x Technology AI-related including: ML, AI, deep-learning, algorithm, automated, data-driven, 
computer-assisted, expert-systems, neural networks, support vector machines, decision trees, 
logistic regression, statistical mapping, statistical learning 
x Decision support related: decision support, clinical support, computerised physician order 
entry  
x Setting: healthcare, social care 
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Terms within groups will be combined using the Boolean operator OR and groups were combined 
using the Boolean operator AND.  
 
Study selection 
Titles and abstracts of studies identified from the searches will be checked by two investigators. The 
full text of all retrieved potentially eligible studies will be independently assessed against the above 
criteria. The investigators will decide which of the studies satisfy the inclusion criteria and the 
methodological quality of eligible studies will be recorded (discussed below). Any disagreements will 
be resolved by discussion, with referral to a third member of the research team, if necessary. 
 
Quality assessment and analysis 
Formal quality assessment of eligible studies will be independently undertaken by two reviewers using 
the methods detailed in section eight of the Cochrane Handbook for Systematic Reviews of 
Interventions. Disagreements will be resolved through discussion, with arbitration by a third reviewer 
if agreement cannot be reached.  
 
Data extraction  
Data will be abstracted onto a customised data extraction sheet by two independent reviewers. Any 
disagreements will be resolved through discussion, with arbitration by a third reviewer if necessary. 
Variables to be extracted will include: author and year; title of the study; country of origin; health/care 
setting; technology application(s); impact on practitioner performance; impact on patient outcomes; 
estimates of effectiveness; barriers and facilitators identified. Key findings from each study will be 
summarised and presented in tables.  
 
Data analysis 
A quantitative synthesis is likely to prove inappropriate due to the heterogeneity of technologies and 
care contexts. Data will therefore be descriptively summarised and narratively synthesised. We will 
follow four main steps in conducting an interpretive synthesis of our findings: (1) noting the range of 
functions and uses of existing systems; (2) noting the various methods used to measure impact and 
their appropriateness; and (3) summarising evidence of effectiveness. 
  
ETHICS AND DISSEMINATION 
Ethical issues 
Formal ethical approval and informed consent is not required, as this work does not draw on primary 
data from human participants. 
 
Publication plan 
The systematic review protocol will be registered with the PROSPERO International Prospective 
Register of Systematic Reviews (http://www.crd.york.ac.uk/prospero) and reported using Preferred 
Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guidelines in the peer-reviewed 
literature.  
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Appendix 3 ± Topic guides and observation recording sheet 
Sample topic guide for interviews with policymakers 
Background and role of interviewee 
What is your understanding of what DSS is? 
Where does decision support fit into the services you are delivering? 
Views on DSS systems: expected benefits/impact of and drivers for DSS ± which domains are of 
particular policy interest 
Prompts: 
x Self-management 
x Shared decision-making  
x Strengthening prevention and improving public health 
x Reduction of unwarranted variation and harm 
x Collaboration and coordination of care across sectors 
x Maximising efficiency by reducing over-use of services. 
What might enable the realisation of these benefits and over what time frame 
Views on how impact can be achieved within and across settings and how it can be measured 
Potential challenges implementing/using proposed solutions as well as ways to address these and 
ensure sustainability 
What are potential unintended consequences and how can these be minimised/mitigated? 
How would you like/expect the DSS landscape to evolve over the medium to longer-term?  
How do you think the future of DSS could/should look like? 
'HILQLWLRQVRI³VXFFHVV´IURPYDULRXVSHUVSHFWLYHV 
In your area what would make it worthwhile to fund DSS work going forward?  
Prompts: 
x Which areas? Do any of the current early adopter /proof of concept projects seems especially 
relevant to your needs? 
x Economic factors 
x Any technical/technology related factors? 
Expected challenges? 
Anything else? 
Sample topic guide for interviews with clinical leads 
The interviews will follow user groups organised by Scottish Government (a few days after the demo 
to let interviewees digest the content). Some interviewees may not have been to the system demos 
± these will be shown a short demo by the interviewer before the interview. 
Phase 0 - background 
x ,QWHUYLHZHH¶VEDFNJURXQGLQFOXGLQJFXUUHQWSRVLWLRQDQG specific role in relation to the early 
adopter area 
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o Informatics literacy and skills 
 
Phase 1 ± wider impact of Decision Support Systems, what Scottish Government hopes 
Decision Support Systems will achieve more generally ± what do they think? 
o Expected impact/benefits (prompt: align with outcomes identified by Scottish 
Government in WP1) 
o How can these be measured 
o Can use Diabetes as a prompt: The system was associated with improved efficiency 
in working practices, but at the same time has resulted in a dramatic improvement in 
adherence to national guidelines ± patients were 3-4 times more likely to receive 
appropriate screening for diabetes-related complications.   
 
Phase 2 ± exploring reactions to the system demo 
x Experience of using Cambio and initial impressions of use ± in relation to clinical scenarios 
o Positive features 
o Expected impact/benefits and how these could be measured 
o Initial and expected problems and concerns as well as ways to address these and 
ensure sustainability 
o Changes in work practices (new practices, workarounds, impact on the way the team 
functions and on patients/carers) and perceptions surrounding impact on skills and 
knowledge (and resulting attitudes and behaviours) 
o Changes that the user would like to see happening in the system (prompt: extra 
functionality)  
o Perceived/anticipated consequences of the system on the quality of care, information 
flow, patient experience, roles and practices of (health and care) professionals, the 
organisation, the local community, efficiency? Data use?  
o Training received and ongoing support that may be needed 
 
Phase 3 - What further development of the Decision Support Systems/wider system are needed 
to help realise more of these Scottish Government goals?    
x Views on how it will integrate with existing local and national systems 
x Views on multi-channel, vendor neutral nature of system  
x Thoughts on the national and local implementation strategy  
x :KDWZLOO³VXFFHVV´ORRNOLNHWR\RX" 
Sample observation schedule 
At the start of the user group, during the welcome and introduction slot, the researcher will be 
introduced to the group by the meeting chair. The facilitator will reiterate that participants can withdraw 
their consent at any time. There will also be dedicated time to ask the researcher questions and 
participants will be encouraged to approach the researcher directly, should they have any questions. 
During the introduction, every participant will introduce themselves so that the researcher can locate 
those who have consented to observation and note the locations of those to be omitted.  
All participants will have been contacted/informed about the study in advance and will have given 
either their consent or would have refused to be observed. Job titles and gender of non-consenters 
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will not be recorded and the job title of those present will only be recorded if it is volunteered at the 
beginning of the meeting. 
Should there be any late additions, these will be approached by the researcher directly in order to re-
state their role. 
During observations of a user group workshop, the researcher will focus on observing participants 
and the way information is shared regarding facilitators and barriers to implementing and evaluating 
Decision Support in practice.  
The researcher will not record any part of the discussion in which a non-participant is speaking.  
The researcher will aim at recording/noting descriptive elements including the following: 
 Description of the layout and the way a facilitator uses the space;  
 Description of the actors ± the gender and job title (the researcher will not record names) 
 Insights to process ± The way a system was conceived, implemented and used 
 Evaluation pathways and methodologies 
 Insights to outcome ± practice/skills, workflow, behaviour/attitudes  
 Reactions of actors to specific questions 
 Feelings ± UHVHDUFKHU¶VRZQLPSUHVVLRQVIHHOLQJV in relation to the observation 
The researcher may follow up this descriptive element with more focussed observation of particular 
details that the researcher feels warrant further investigation in the light of the theoretical framework 
and emerging issues. 
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Appendix 4 ± Extended version of the framework and integration with 
the literature 
Technological factors 
Table 1: Technological factors impacting implementation, adoption and optimisation based 
on the literature 
Usability Performance Adaptability 
and flexibility 
Dependability Data 
availability, 
integrity and 
confidentiality 
Data 
accuracy 
Sustainability 
Is there 
alignment 
between work 
processes and 
software 
specifications? 
Does use of 
the system 
slow down 
workers? 
Are systems 
flexible enough 
to fit in with the 
nature of clinical 
responsibilities 
and local 
needs? 
Is the system 
reliable and 
stable? 
Is data held 
within the 
system 
available, 
accessible and 
usable to those 
who need it? 
Is the 
data held 
in the 
system 
accurate? 
Will the 
technology be 
easily scaled 
up? 
Does the user 
have to 
navigate a 
large number of 
interfaces? 
Does the 
system 
improve the 
efficiency of 
workers? 
Can system 
design be 
changed to 
some extend to 
suit emerging 
needs? 
 Are data in and 
outputs of the 
system 
accurate and 
appropriate? 
Is the 
data held 
in the 
system 
trusted? 
Is use of the 
technology 
sustainable? 
Is the 
technology 
easy to 
operate? 
Does the 
system needs 
effectively 
integrate with 
existing 
systems? 
Is information in 
the system 
organized by 
relevance to the 
specific use and 
type of user? 
 Is data only 
available to 
those who need 
it? 
  
 
References 
Shaw J, Shaw S, Wherton J, Hughes G, Greenhalgh T. Studying scale-up and spread as social 
practice: theoretical introduction and empirical case study. Journal of medical Internet research. 2017 
Jul;19(7). 
Sittig DF, Ash JS, Singh H. The SAFER guides: empowering organizations to improve the safety and 
effectiveness of electronic health records. Am J Manag Care 2014;20:418±23. 
Greenhalgh T, Stramer K, Bratan T, Byrne E, Mohammad Y, Russell J. Introduction of shared 
electronic records: multi-site case study using diffusion of innovation theory. BMJ 2008 Oct 
23;337:a1786. 
Doebbeling BN, Chou AF, Tierney WM. Priorities and strategies for the implementation of integrated 
informatics and communications technology to improve evidence-based practice. Journal of general 
internal medicine. 2006 Feb 1;21(2):S50. 
Beuscart-=pSKLU0&$QFHDX[)&ULQTXHWWH95HQDUG-0,QWHJUDWLQJXVHUV¶DFWLYLW\PRGHOLQJLQWKH
design and assessment of hospital electronic patient records: the example of anesthesia. International 
journal of medical informatics. 2001 Dec 1;64(2-3):157-71. 
Keshavjee K, Bosomworth J, Copen J, Lai J, Kucukyazici B, Lilani R, Holbrook AM. Best practices in 
EMR implementation: a systematic review. InAMIA 2006. 
Rose AF, Schnipper JL, Park ER, Poon EG, Li Q, Middleton B. Using qualitative studies to improve 
the usability of an EMR. Journal of Biomedical Informatics 2005; 38(1):51-60. 
31 
 
Social/human factors 
Table 2: Social/human factors impacting implementation, adoption and optimisation based on 
the literature (6,7,10-17) 
User 
satisfacti
on 
Complete/cor
rect use 
Attitudes 
and 
expectatio
ns 
Engagem
ent 
Experienc
es 
Workload/ben
efits 
Work 
processes 
User input 
in design 
Are users 
satisfied 
with the 
technolog
y? 
Are features 
and 
functionality 
implemented 
and used as 
intended? 
What 
benefits do 
users 
expect from 
using the 
technology 
and how 
can these 
be 
measured? 
Do users 
resist 
use? 
Have 
users got 
negative 
experience 
with 
previous 
technologi
es? 
Are the 
benefits and 
efforts 
relatively equal 
for all 
stakeholders? 
Have work 
processes 
been 
mapped 
before the 
implementati
on? 
Is there 
effective 
communicat
ion between 
designers, 
IT staff and 
end-users 
as well as 
between 
manageme
nt and end-
users? 
Are there 
any 
concerns 
in relation 
to the 
technolog
y? 
 Do users 
generally 
accept the 
technology? 
Have 
users 
been 
actively 
engaged 
from the 
start? 
Does the 
system 
increase 
cognitive 
demands 
on users? 
Do users find 
the system of 
value? 
Does the 
system 
change 
relationships 
with patients, 
patterns of 
communicati
on, and 
professional 
responsibiliti
es (e.g. 
increase in 
administrativ
e tasks)? 
Is user 
feedback 
incorporate
d in system 
design? 
  Do users 
understand 
the drive 
behind the 
implementa
tion (safety, 
quality, 
efficiency)? 
  Does the 
system 
increase 
workloads for 
users? 
Are 
workarounds 
being 
employed by 
users to 
address 
perceived 
system 
limitations? 
 
  Are 
emerging 
concerns 
listened to 
and 
addressed? 
   Are these 
changes 
remaining 
stable over 
time? 
 
  Has the 
technology 
fulfilled user 
expectation
s? 
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Organisational context 
Table 3: Organisational factors impacting implementation, adoption and optimisation based 
on the literature  
Leadership 
and 
managemen
t 
Communicati
on  
Timelines Vision Training 
and 
support 
Champio
ns 
Resources Monitoring 
and 
optimisati
on 
Is the 
implementati
on a top 
management 
priority? 
Have benefits 
and 
disbenefits of 
the technology 
been 
communicated 
to each 
stakeholder 
group? 
Are 
implementati
on timelines 
adequate? 
What 
benefits do 
organisation
s expect 
from 
implementin
g the 
technology 
and how can 
these be 
measured? 
Is the 
training 
adequate 
and 
realistic? 
Are 
champion
s and 
boundary 
spanners 
effectively 
utilised? 
Is 
implementati
on 
adequately 
resourced? 
(includes 
technology, 
change 
management 
and 
maintenance
) 
Is system 
performanc
e and use 
monitored 
and 
optimised 
over time? 
Are 
management 
structures to 
support the 
implementati
on 
adequate? 
Have aims 
been 
effectively 
communicated
? 
 Is a coherent 
vision driving 
development
s? 
Is time 
allocated 
to train 
users 
effectivel
y? 
Do 
negative 
champion
s have 
influence? 
Has the 
organisation 
capacity to 
innovate? 
Are 
lessons 
learnt 
captured 
and 
incorporate
d in future 
efforts? 
Is the 
implementati
on strategy 
sufficiently 
flexible? 
Have realistic 
timelines been 
effectively 
communicated
? 
 Is there a 
business 
need for the 
system? 
(building a 
Is 
effective 
support 
in place 
and there 
  Is the 
system 
adequately 
piloted? 
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solution, not 
just 
implementin
g a system) 
when 
needed? 
Is staff 
ownership 
promoted 
through 
involvement 
in decision 
making? 
Have 
concerns been 
adequately 
been 
addressed? 
 Is the vision 
realistic? 
Is the 
training 
well 
timed 
(i.e. not 
too long 
before 
go-live? 
  Is risk 
assessmen
t and 
mitigation 
in place? 
Has the 
implementati
on team 
defined roles 
and is 
adequately 
resource? 
Has the 
implementatio
n strategy 
been 
communicated
? 
     Has a 
budget for 
evaluation 
activities 
been 
allocated? 
 Is 
communicatio
n between 
management 
and users two-
way? 
      
 Are there 
open channels 
of 
communicatio
n between 
users, 
managers and 
suppliers? 
      
 
References 
Shaw J, Shaw S, Wherton J, Hughes G, Greenhalgh T. Studying scale-up and spread as social 
practice: theoretical introduction and empirical case study. Journal of medical Internet research. 2017 
Jul;19(7). 
Aarts J, Doorewaard H, Berg M. Understanding Implementation: The Case of a Computerized 
Physician Order Entry System in a Large Dutch University Medical Center. Journal of the American 
Medical Informatics Association 2004; 11(3):207-216. 
Singh, H. and Sittig, D.F., 2016. Measuring and improving patient safety through health information 
technology: The Health IT Safety Framework. BMJ Qual Saf, 25(4), pp.226-232. 
Clemmer TP. Computers in the ICU: where we started and where we are now. [Review] [72 refs]. 
Journal of Critical Care 2004;(4):201-207. 
Pendergast DK, Buchda VL. Charting the course. A quality journey. Nursing Administration Quarterly 
27(4):330-5, 2003; 27(4):330-335. 
Hendy J, Reeves BC, Fulop N, Hutchings A, Masseria C. Challenges to implementing the national 
programme for information technology (NPfIT): a qualitative study.[see comment]. BMJ 2005; 
331(7512):331-336. 
Morrison C, Jones M, Blackwell A, Vuylsteke A. Electronic patient record use during ward rounds: A 
qualitative study of interaction between medical staff. Critical Care 2008; 12(6). 
McGowan JJ, Cusack CM, Poon EG. Formative evaluation: a critical component in EHR 
implementation. Journal of the American Medical Informatics Association 2008; 15(3):297-301. 
34 
 
Wider macro-environment 
Table 4: Macro-environmental factors impacting implementation, adoption and optimisation 
based on the literature  
Media Professional 
groups  
Political 
context 
Economic 
considerations 
and incentives 
Legal and 
regulatory 
aspects 
Suppliers  Measuring 
impact  
How is the 
technology 
viewed by 
the media? 
How is the 
technology 
viewed by 
professional 
groups? 
What benefits 
do 
policymakers 
expect from the 
technology and 
how can these 
be measured? 
Are there clear 
incentives for 
organisations 
and users to 
implement? (e.g. 
improvements in 
quality of care) 
Have legal 
and 
regulatory 
frameworks 
been 
established? 
Is supplier 
management 
effectively 
organised? 
Are various 
stakeholders 
working 
together to 
define, validate, 
test and refine 
outcome 
measures and 
measurement 
strategies?  
  What is the 
national 
approach to 
achieving 
interoperability 
and does the 
system align 
with this? 
Is sufficient 
funding in place 
to support the 
initiative? 
 Is 
responsibility 
for safety 
shared with 
suppliers? 
Is there vendor 
involvement to 
enable system 
wide 
learning? (e.g. 
collection of 
potential safety 
risks and 
unintended 
consequences 
of systems?) 
  Is there 
sufficient local 
input in 
decision 
making whilst 
still providing 
central 
guidance? 
  How has the 
system been 
procured? 
Are both 
retrospective 
and prospective 
outcomes 
measures 
used? 
  Is there a 
coherent vision, 
consistent 
approach and a 
clear direction 
of travel? 
   Are outcome 
measured 
important, 
clinically 
acceptable, 
transparent, 
feasible and 
usable? 
  Is there a 
strategy for 
scale-up and 
sustainability? 
   Are there 
measures of 
improved value 
and improved 
outcomes? 
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